MeSH Browser

MeSH Supplementary: cabotegravir
Unique ID: C584914
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C584914
Entry Term(s): (3S,11aR)-N-((2,6-difluoropyridin-3-yl)methyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro(1,3)oxazolo(3,2-a)pyrido(1,2-d)pyrazine-8-carboxamide; Apretude; GSK-1265744; GSK-1265744A; GSK-1265744B; GSK1265744; GSK1265744A; GSK1265744B; GSK744; N-((2,4-difluorophenyl)methyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro(1,3)oxazolo(3,2-a)pyrido(1,2-d)pyrazine-8-carboxamide; S-265744; S-265744B; Vocabria; cabotegravir extended-release injectable suspension; cabotegravir sodium; sodium (3S,11aR)-8-(((2,4-difluorophenyl)methyl)carbamoyl)-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo(3,2-a)pyrido(1,2-d)pyrazin-6-olate
Pharm Action: HIV Integrase Inhibitors
Registry Numbers: HMH0132Z1Q; 0; 3L12PT535M
Related Numbers: 3L12PT535M
Heading Mapped to: *Pyridones; *Diketopiperazines
Frequency: 173
Note: an HIV integrase strand transfer inhibitor
Source: HIV Clin Trials. 2013 Sep-Oct;14(5):192-203
Date of Entry: 2013/12/12
Revision Date: 2022/01/07

Concept UI: M0589573
Registry Numbers: 0
Terms: GSK1265744 Preferred Term
Term UI T851942
Date12/12/2013
LexicalTag LAB
ThesaurusID NLM (2014); GSK-1265744A
Term UI T001116720
Date01/07/2022
LexicalTag LAB
ThesaurusID NLM (2022); S-265744
Term UI T001116721
Date01/07/2022
LexicalTag LAB
ThesaurusID NLM (2022); GSK-1265744
Term UI T001116718
Date01/07/2022
LexicalTag LAB
ThesaurusID NLM (2022); GSK744
Term UI T856932
Date03/19/2014
LexicalTag LAB
ThesaurusID NLM (2014); GSK1265744A
Term UI T001116719
Date01/07/2022
LexicalTag LAB
ThesaurusID NLM (2022)

cabotegravir MeSH Supplementary Concept Data 2025